Boston Scientific Reports the Acquisition of Cortex
Shots:
- Boston Scientific has agreed to acquire Cortex (an Ajax Health company), strengthening its electrophysiology portfolio for treating complex atrial fibrillation. Financial terms were undisclosed; closing is anticipated during H1’25, pending customary conditions
- The acquisition adds Cortex’ FDA-approved OptiMap System to Boston’s portfolio. Cortex has concluded the system’s FLOW-AF study, showing 51% improved AF freedom 1yr. post-ablation vs conventional therapy, plus has begun another global RESOLVE-AF for detecting extra-pulmonary vein sources in 300 patients
- The OptiMap System detects active AF sources through a basket catheter & algorithm, enabling physicians create personalized ablation strategies
Ref: Boston Scientific | Image: Boston Scientific
Related News:- Boston Scientific Reports the Acquisition of Silk Road Medical
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
